This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Universitéde Strasbourg. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015
Title: Corinne Liegeois: Innovator in Fluorescent Compounds for Medical Diagnosis
Introduction
Corinne Liegeois is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of fluorescent compounds, particularly in their application for medical diagnostics. Her innovative work focuses on the development of novel compounds that can aid in the detection of neurodegenerative diseases.
Latest Patents
Corinne Liegeois holds a patent for "Fluorescent boron-substituted dipyrromethenes and use thereof for diagnosis." This invention relates to new fluorescent compounds derived from non-fluorinated dipyrromethene-boron. The patent outlines a method for preparing these compounds and their use in fluorescent marking of biological molecules. The marked biological molecules can be utilized in detection methods, especially in medical diagnostics. Notably, these detection methods are particularly beneficial for diagnosing neurodegenerative diseases such as Alzheimer's disease. She has 1 patent to her name.
Career Highlights
Throughout her career, Corinne has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Université de Strasbourg. Her research has significantly advanced the understanding and application of fluorescent compounds in the medical field.
Collaborations
Corinne has collaborated with notable colleagues, including Jean De Barry and Raymond Ziessel. Their combined expertise has contributed to the success of her innovative projects.
Conclusion
Corinne Liegeois is a trailblazer in the development of fluorescent compounds for medical diagnostics. Her work not only enhances the detection of diseases but also paves the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile